MedPath
HSA Approval

DAUNOCIN FOR INJECTION 20 mg/vial

SIN11002P

DAUNOCIN FOR INJECTION 20 mg/vial

DAUNOCIN FOR INJECTION 20 mg/vial

June 29, 1999

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

L01DB02

daunorubicin

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

DAUNORUBICIN HCl EQV DAUNORUBICIN

20 mg/vial

Daunorubicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DAUNOCIN FOR INJECTION 20 mg/vial - HSA Approval | MedPath